Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
![](https://fprimecapital.com/wp-content/uploads/2019/01/alternate-healthcare-illustration-1024x1024.jpg)
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
March 20, 2019 -
Nasdaq
Coherus BioSciences Announces New Employment Inducement Grants
March 19, 2019 -
Nasdaq
Early stage cancer biotech Precision BioSciences sets terms for $126 million IPO
March 18, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.
March 18, 2019 -
GlobeNewswire
Coherus BioSciences Receives Transitional Pass-Through Status from CMS
March 18, 2019 -
GlobeNewswire
Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Office
March 18, 2019 -
PR Newswire
Artemis Health Raises $25 Million Series C Led by Bessemer Venture Partners
March 14, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Acceptance of OTL-200 Abstract for MLD at the 45th Annual Meeting of the European Society for Blood and Bone Marrow Transplantation (EBMT)
March 11, 2019 -
PR Newswire
TraceLink Submits an Interoperable Blockchain Network Solution for FDA DSCSA Pilot Project Program
March 11, 2019 -
Business Wire
Valor Performance Welcomes 12 Elite Athletes to Business Coaching Team
March 8, 2019 -
GlobeNewswire
Owkin Closes A New Venture Round Led By F-Prime Capital And Eight Roads Ventures; Appoints Health Tech Veteran Parker Moss As Chief Business Officer
March 7, 2019 -
PR Newswire
Next Generation ACO Providers on PatientPing’s Network Achieve More than $100 Million in Shared Savings
March 7, 2019 -
Business Wire
Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines
March 6, 2019 -
PR Newswire
TraceLink Announces Smart Inventory Tracker, an End-to-End Warehouse Compliance Solution Built on its Integrated Digital Supply Network Platform
March 5, 2019 -
PR Newswire
Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation
March 4, 2019 -
Marketplace
Precision BioSciences on deck for IPO
March 2, 2019 -
GlobeNewswire
Hua Medicine completes patient enrollment for Phase III monotherapy trial of dorzagliatin
March 1, 2019 -
Fierce Biotech
Denali expands antibody discovery deal with AbCellera
February 28, 2019 -
Business Wire
Nebula Genomics Recognizes World Rare Disease Day With Advocacy Collaborations, Opens Platform to Rare Disease Patients, Researchers
February 28, 2019 -
Drug Development Technology
Innovent begins Tyvyt dosing in liver cancer patients
February 28, 2019 -
PR Newswire
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards
February 27, 2019 -
PR Newswire
Centivo Rounds Out Leadership Team to Prepare for Expansion
February 27, 2019 -
PR Newswire
TraceLink Achieves 59% Overall Revenue Growth for Q4 2018
February 26, 2019 -
GlobeNewswire
Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD
February 25, 2019 -
Ivenix
Ivenix Appoints John Douglass as Board of Directors Executive Chair
February 25, 2019 -
PR Newswire
Humana and PatientPing Announce Agreement to Improve Care Coordination for Members Across North Carolina
February 20, 2019 -
PR Newswire
Modis Therapeutics Announces that MT1621 Receives Breakthrough Therapy Designation from FDA for the Treatment of TK2 Deficiency
February 19, 2019 -
PR Newswire
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients
February 17, 2019 -
GlobeNewswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer’s Disease
February 15, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of an Anti-OX40 Antibody
February 13, 2019 -
Business Wire
Caribou Biosciences Announces Expansion of Scientific Advisory Board
February 12, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Acceptance of Late-Breaking Abstracts of OTL-101 for ADA-SCID and OTL-102 for X-CGD at the 2019 Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
February 6, 2019 -
Globe Newswire
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
February 4, 2019 -
GlobeNewswire
Hua Medicine Initiates First Combination Study of Dorzagliatin with a DPP-4 Inhibitor in the United States
February 1, 2019 -
PR Newswire
2019 Best in KLAS Report Ranks Protenus No. 1 in Patient Privacy Monitoring
January 31, 2019 -
Business Wire
VitalWare™ Achieves #1 in KLAS Revenue Cycle – Chargemaster Management Category for 2019
January 31, 2019 -
Center for Biosimilars
Innovent Seeks Chinese Regulatory Approval for Proposed Biosimilar Bevacizumab
January 31, 2019 -
GlobeNewswire
Menlo Therapeutics Announces Late-Breaking Oral Presentation at the American Academy of Dermatology Annual Meeting
January 30, 2019 -
PR Newswire
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
January 28, 2019 -
GlobeNewswire
Acacia Pharma Announces Supportive Cardiac Safety Data for BARHEMSYS™
January 23, 2019 -
Pipeline Review
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
January 22, 2019 -
Equity Bulls
Caplin Steriles gets INR 218 crore investment from Eight Roads Ventures and F-Prime Capital
January 18, 2019 -
PR Newswire
NextLevel Health Partners, Inc., Announces Partnership With PatientPing To Improve Member Care And Coordination
January 17, 2019 -
PR Newswire
Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
January 17, 2019 -
Business Wire
Precision BioSciences Announces Formation of Scientific Advisory Board with Anderson, Kantarjian, Schinazi and Turtle
January 16, 2019 -
Baltimore Business Journal
Protenus to expand, move HQ to Brown’s Wharf in Fells Point
January 15, 2019 -
Market Wired
Menlo Therapeutics’ Serlopitant Granted Breakthrough Therapy Designation by FDA for the Treatment of Pruritus Associated with Prurigo Nodularis
January 15, 2019 -
Parkinson's News Today
Sirion and Denali Collaborating to Develop Gene Therapies for Neurodegenerative Diseases
January 14, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody
January 14, 2019 -
Fierce Biotech
Orchard Therapeutics’ 2019: Pipeline progress, breaking ground on its $90M manufacturing site
January 11, 2019 -
Boston Business Journal
Health software startup PatientPing plans to hire 100, doubling size in 2019
January 11, 2019 -
PR Newswire
Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines
January 4, 2019 -
PR Newswire
Avidity Biosciences’ Arthur A. Levin Publishes Review of Therapeutic Approaches of Targeting RNA in the New England Journal of Medicine
January 3, 2019 -
PR Newswire
Mercy Health Network Partners with PatientPing to Improve Transitions of Care Across Iowa
January 3, 2019 -
Citizen Tribune
Precision BioSciences Appoints Rare Disease Executive Shalini Sharp to Its Board of Directors
December 20, 2018 -
Business Wire
CynergisTek and Protenus Join Forces as Partners to Protect Patient Privacy
December 20, 2018 -
Globe Newswire
Cytek Biosciences Ships 100th Advanced Flow Cytometry System
December 20, 2018 -
Business Wire
Compass Therapeutics Expands Leadership Team with Appointments of Chief Medical Officer and Chief Financial Officer
December 19, 2018 -
Business Wire
Semma Therapeutics Expands Executive Leadership Team
December 18, 2018 -
Carestack
CareStack® Announces Partnership with DentalXChange to Help Dental Practices Speed Claims Processing and Enhance Administrative Workflows
December 17, 2018 -
PRNewswire
Devoted Health Expands Provider Network With Top Hospitals in Lakeland Area
December 17, 2018 -
PRNewswire
Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China
December 16, 2018 -
Business Insider
VitalWare™ Introduces HospitalPriceIndex.com In Response To Governmental Pricing Transparency Mandate
December 14, 2018 -
B3C Newswire
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
December 14, 2018 -
Nasdaq
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
December 13, 2018 -
Business Wire
Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors
December 12, 2018 -
Business Wire
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing
December 12, 2018 -
PRNewswire
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
December 12, 2018 -
Globe Newswire
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 10, 2018 -
Market Screener
Genomics plc Announces second close of Series B financing, raising a further £8m, bringing the total round to £33m
December 10, 2018 -
Globe Newswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
December 10, 2018 -
Business Wire
Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space
December 6, 2018 -
Globe Newswire
Unum Therapeutics Inc. (UMRX) Secures U.S. Patent for ACTR Technology
December 6, 2018 -
Globe Newswire
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting
December 5, 2018 -
Biospace
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101
December 5, 2018 -
Business Wire
Turnstone Biologics Unveils Novel Vaccinia Oncolytic Viral Immunotherapy Platform
November 30, 2018 -
BC Extra
Chi-Med, Innovent Enter Global Cancer Partnership
November 30, 2018 -
PRNewswire
Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors
November 29, 2018 -
Business Wire
Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy
November 27, 2018 -
PRNewswire
Blue Cross Blue Shield of Massachusetts Expands Medicare Network to Include Iora Health
November 20, 2018 -
PRNewswire
TraceLink Achieves 55% Overall Revenue Growth for Q3 2018
November 19, 2018 -
PRNewswire
Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
November 16, 2018 -
CareStack® Partners with Callpop to Expand Patient Communication Capabilities for Dental Practices Nationwide
November 14, 2018 -
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
November 14, 2018 -
PRNewswire
Zeel Partners With Stride Health To Bridge Insurance Gap For Massage Therapists
November 14, 2018 -
Globe Newswire
Cytek Biosciences Continues Momentum by Strengthening Executive Team, Adding Board Members
November 13, 2018 -
Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist
November 13, 2018 -
Modis Therapeutics Announces Prime Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency
November 13, 2018 -
PRNewswire
NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab)
November 12, 2018 -
Globe Newswire
Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium
November 9, 2018
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.